Insider · CIK 0001200160

FARRELL CHRISTINE

Reports to the SEC for 2 companies · TUALATIN, OR

sec.gov

Transactions

Companies

Filings

CIK

0001200160

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-28	ODYYOdyssey Health, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+500K sh	$0.10	+$50K	500,000
2023-12-29	ODYYOdyssey Health, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+500K sh	$0.10	+$50K	500,000
2023-01-12	ODYYOdyssey Health, Inc. · Restricted Stock Unit (Right to Buy)A Award	Chief Financial Officer	AAward	+400K sh	$0.30	+$120K	1,700,000
2023-01-12	ODYYOdyssey Health, Inc. · Restricted Stock Unit (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	$0.30	+$30K	1,300,000
2022-10-14	ODYYOdyssey Health, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+500K sh	$0.32	+$159K	1,100,000
2022-05-19	ODYYOdyssey Health, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+300K sh	$0.30	+$90K	1,300,000
2022-05-19	ODYYOdyssey Health, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+300K sh	$0.30	+$90K	1,600,000
2021-01-01	ODYYOdyssey Health, Inc. · Restricted Stock Unit (Right to Buy)A Award	Chief Financial Officer	AAward	+1M sh	$0.18	+$180K	1,000,000
2011-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+25K sh	—	—	318,024
2011-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−25K sh	—	—	0
2010-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−39K sh	—	—	461,421
2010-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+39K sh	—	—	293,024
2010-06-10	BIOJECT MEDICAL TECHNOLOGIES INCOption (Right to buy)A Award	VP of Finance	AAward	+240K sh	$0.15	+$36K	509,171
2010-04-23	BIOJECT MEDICAL TECHNOLOGIES INCStock Option (Right-to-buy)A Award	VP of Finance	AAward	+150K sh	—	—	269,171
2009-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+24K sh	—	—	225,443
2009-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+25K sh	—	—	254,024
2009-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−24K sh	—	—	164,796
2009-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−25K sh	—	—	119,171
2009-12-07	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitP Purchase	VP of Finance	PPurchase	−5,000 sh	—	—	188,796
2009-12-07	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+5,000 sh	—	—	201,443
2009-03-08	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−25K sh	—	—	193,796
2009-03-08	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+25K sh	—	—	196,443
2009-01-30	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−75K sh	—	—	218,796
2009-01-30	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+75K sh	—	—	171,443
2009-01-19	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−834 sh	—	—	293,796
2009-01-19	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+834 sh	—	—	96,443
2008-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+24K sh	—	—	95,609
2008-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−24K sh	—	—	294,630
2008-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	−24K sh	—	—	95,609
2008-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+24K sh	—	—	95,609
2008-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−24K sh	—	—	294,630
2008-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	+24K sh	—	—	294,630
2008-06-25	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitA Award	VP of Finance	AAward	+75K sh	—	—	323,630
2008-01-22	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	VP of Finance	MExercise/Conversion	−833 sh	—	—	217,030
2008-01-22	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+833 sh	—	—	41,109
2007-12-31	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+10K sh	—	—	43,176
2007-12-31	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	VP of Finance	MExercise/Conversion	−10K sh	—	—	217,863
2007-12-31	BIOJECT MEDICAL TECHNOLOGIES INCF Tax Payment	VP of Finance	FTax Payment	−2,900 sh	$0.55	−$1,595	40,276
2007-06-14	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitsA Award	VP of Finance	AAward	+45K sh	—	—	157,167
2007-03-26	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+2,500 sh	—	—	29,626
2007-03-26	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	VP of Finance	MExercise/Conversion	−2,500 sh	—	—	112,167
2007-03-10	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+500 sh	—	—	27,126
2007-03-10	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitsM Exercise/Conversion	VP of Finance	MExercise/Conversion	−500 sh	—	—	64,667
2006-10-02	BIOJECT MEDICAL TECHNOLOGIES INCRestricted Stock UnitM Exercise/Conversion	VP of Finance	MExercise/Conversion	−5,000 sh	—	—	36,500
2006-10-02	BIOJECT MEDICAL TECHNOLOGIES INCM Exercise/Conversion	VP of Finance	MExercise/Conversion	+5,000 sh	$0.89	+$4,450	25,293
2006-06-01	BIOJECT MEDICAL TECHNOLOGIES INCRestricted StockA Award	VP of Finance	AAward	+30K sh	$1.29	+$38.7K	41,500

Recent filings

Accepted (ET)
Jul 164
FARRELL CHRISTINE0001683168-24-004905
SEC(opens sec.gov)
Jan 24
FARRELL CHRISTINE0001683168-24-000025
SEC(opens sec.gov)
Jan 134
FARRELL CHRISTINE0001683168-23-000191
SEC(opens sec.gov)
Oct 194
FARRELL CHRISTINE0001683168-22-006967
SEC(opens sec.gov)
Jun 84
FARRELL CHRISTINE0001683168-22-004240
SEC(opens sec.gov)
Mar 14
FARRELL CHRISTINE0001683168-21-000746
SEC(opens sec.gov)
Jan 44
BIOJECT MEDICAL TECHNOLOGIES INC0000810084-12-000001
SEC(opens sec.gov)
Jan 44
BIOJECT MEDICAL TECHNOLOGIES INC0000810084-11-000001
SEC(opens sec.gov)
Jun 114
BIOJECT MEDICAL TECHNOLOGIES INC0000810084-10-000014
SEC(opens sec.gov)
Apr 264
BIOJECT MEDICAL TECHNOLOGIES INC0000810084-10-000010
SEC(opens sec.gov)
Feb 124/A
BIOJECT MEDICAL TECHNOLOGIES INC0000810084-10-000005
SEC(opens sec.gov)
Jan 44
BIOJECT MEDICAL TECHNOLOGIES INC0000810084-10-000001
SEC(opens sec.gov)
Dec 84
BIOJECT MEDICAL TECHNOLOGIES INC0000810084-09-000020
SEC(opens sec.gov)

Companies

Address

20245 SW 95TH AVENUE

TUALATIN, OR, 97062